<?xml version='1.0' encoding='utf-8'?>
<chapter num="49" heading="Pharmacy Services Administrative Organizations" title_num="31" subtitle_num="10">
  <regulation prefix="Regulation" num=".01" heading="Scope.">
    <text>This chapter applies to all contractual agreements between a pharmacy services administrative organization and an independent pharmacy in which a pharmacy services administrative organization negotiates on behalf of an independent pharmacy with purchasers or pharmacy benefit managers for prescription drug coverage or benefits, medical devices, or biologics provided to a beneficiary of a purchaser.</text>
  </regulation>
  <regulation prefix="Regulation" num=".02" heading="Definitions.">
    <paragraph num="A.">
      <text>In this chapter, the following terms have the meanings indicated.</text>
    </paragraph>
    <paragraph num="B.">
      <text>Terms Defined.</text>
      <paragraph num="(1)">
        <text>“Appeal decision” means a written or electronic notice in response to an appeal under this chapter provided to a contracted pharmacy that includes a reason for the appeal denial.</text>
      </paragraph>
      <paragraph num="(2)">
        <text>“Contracted pharmacy” means an independent pharmacy in a pharmacy services administrative contract.</text>
      </paragraph>
      <paragraph num="(3)">
        <text>“Delivered by electronic means” includes:</text>
        <paragraph num="(a)">
          <text>Delivery to an electronic mail address at which an independent pharmacy or contracted pharmacy has consented to receive notice; and</text>
        </paragraph>
        <paragraph num="(b)">
          <text>Posting on an electronic network, together with separate notice to an independent pharmacy or contracted pharmacy directed to the electronic mail address at which the independent pharmacy or contracted pharmacy has consented to receive notice of the posting.</text>
        </paragraph>
      </paragraph>
      <paragraph num="(4)">
        <text>“Independent pharmacy” has the meaning stated in Insurance Article, §15-2001(b), Annotated Code of Maryland.</text>
      </paragraph>
      <paragraph num="(5)">
        <text>“Material change” means a change in control or business operations of a pharmacy services administrative organization after a purchase, merger, or acquisition of a parent company, subsidiary, or other organization.</text>
      </paragraph>
      <paragraph num="(6)">
        <text>Medical Device.</text>
        <paragraph num="(a)">
          <text>“Medical device” means a device used in the diagnosis, treatment, or prevention of disease.</text>
        </paragraph>
        <paragraph num="(b)">
          <text>“Medical device” does not include:</text>
          <paragraph num="(i)">
            <text>Any surgical or dental instrument;</text>
          </paragraph>
          <paragraph num="(ii)">
            <text>Physical therapy equipment;</text>
          </paragraph>
          <paragraph num="(iii)">
            <text>Any x-ray apparatus; or</text>
          </paragraph>
          <paragraph num="(iv)">
            <text>Any component or accessory of any of these items.</text>
          </paragraph>
        </paragraph>
      </paragraph>
      <paragraph num="(7)">
        <text>“Pharmacy benefits manager (PBM)” has the meaning stated in Insurance Article, §15-1601, Annotated Code of Maryland.</text>
      </paragraph>
      <paragraph num="(8)">
        <text>“Pharmacy services administrative contract” has the meaning stated in Insurance Article, §15-2001(d), Annotated Code of Maryland.</text>
      </paragraph>
      <paragraph num="(9)">
        <text>“Pharmacy services administrative organization” or “PSAO” has the meaning stated in Insurance Article, §15-2001(e), Annotated Code of Maryland.</text>
      </paragraph>
      <paragraph num="(10)">
        <text>“Purchaser” has the meaning stated in Insurance Article, §15-2001(f), Annotated Code of Maryland.</text>
      </paragraph>
      <paragraph num="(11)">
        <text>“Working days” means any day that the Maryland Insurance Administration is open for business.</text>
      </paragraph>
    </paragraph>
  </regulation>
  <regulation prefix="Regulation" num=".03" heading="Disclosures to an Independent Pharmacy.">
    <paragraph num="A.">
      <text>A PSAO shall provide to a contracted pharmacy an electronic or paper copy of any contracts, amendments, payment schedules, or reimbursement rates within 5 working days after the execution of a contract, or an amendment to a contract, signed on behalf of the contracted pharmacy by the PSAO.</text>
    </paragraph>
    <paragraph num="B.">
      <text>A PSAO shall provide written notice to an independent pharmacy of any ownership interest or control by a parent company, subsidiary, or other organization before entering into a pharmacy services administrative contract with the independent pharmacy.</text>
    </paragraph>
    <paragraph num="C.">
      <text>A PSAO shall disclose to a contracted pharmacy in writing within 5 working days of any material change of ownership or control or a parent company, subsidiary, or other organization.</text>
    </paragraph>
    <paragraph num="D.">
      <text>The written disclosures required in §§B and C of this regulation shall identify the extent of any ownership interest or control, to include the percent of shares owned, by a parent company, subsidiary, or other organization that:</text>
      <paragraph num="(1)">
        <text>Provides pharmacy services, prescription drug, or device services; or</text>
      </paragraph>
      <paragraph num="(2)">
        <text>Manufactures, sells, or distributes prescription drugs, biologics, or medical devices.</text>
      </paragraph>
    </paragraph>
    <paragraph num="E.">
      <text>The written disclosures required in §§B and C of this regulation may be delivered by electronic means provided:</text>
      <paragraph num="(1)">
        <text>The independent pharmacy or contracted pharmacy has affirmatively consented to that method of delivery and has not withdrawn the consent;</text>
      </paragraph>
      <paragraph num="(2)">
        <text>The independent pharmacy or contracted pharmacy, before giving consent, is provided with a clear and conspicuous statement informing the pharmacy of:</text>
        <paragraph num="(a)">
          <text>Any right or option of the pharmacy to have the notice provided or made available in paper or another nonelectronic form;</text>
        </paragraph>
        <paragraph num="(b)">
          <text>The right of the pharmacy to withdraw consent to have notice delivered by electronic means and any fees, conditions, or consequences imposed in the event consent is withdrawn;</text>
        </paragraph>
        <paragraph num="(c)">
          <text>Whether the consent applies:</text>
          <paragraph num="(i)">
            <text>Only to notices or communications related to a particular transaction; or</text>
          </paragraph>
          <paragraph num="(ii)">
            <text>To identified categories of notices that may be delivered by electronic means during the course of the parties’ relationship; and</text>
          </paragraph>
        </paragraph>
        <paragraph num="(d)">
          <text>The procedures the pharmacy must use to withdraw consent to have notice delivered by electronic means and to update information needed to contact the party electronically;</text>
        </paragraph>
      </paragraph>
      <paragraph num="(3)">
        <text>The independent pharmacy or contracted pharmacy, before giving consent, is provided with a statement of the hardware and software requirements for access to and retention of a notice delivered by electronic means; and</text>
      </paragraph>
      <paragraph num="(4)">
        <text>The process used to obtain consent of the independent pharmacy or contracted pharmacy to have notice delivered by electronic means meets the requirements of Commercial Law Article, Title 21, Subtitle 1, Annotated Code of Maryland.</text>
      </paragraph>
    </paragraph>
  </regulation>
  <regulation prefix="Regulation" num=".04" heading="Internal Appeal Procedures.">
    <paragraph num="A.">
      <text>Each PSAO subject to this chapter shall establish written procedures to investigate and resolve disputes filed against the PSAO by a contracted pharmacy.</text>
    </paragraph>
    <paragraph num="B.">
      <text>The internal appeal procedures shall:</text>
      <paragraph num="(1)">
        <text>Be in writing; and</text>
      </paragraph>
      <paragraph num="(2)">
        <text>Contain administrative processes and safeguards designed to ensure and verify that a PSAO remits payment to a contracted pharmacy in accordance with the pharmacy services administrative contract and Maryland law, and that the contract provisions have not been applied in an arbitrary or capricious manner.</text>
      </paragraph>
    </paragraph>
    <paragraph num="C.">
      <text>The procedures established by the PSAO may not require:</text>
      <paragraph num="(1)">
        <text>More than one appeal before filing a complaint with the Commissioner; or</text>
      </paragraph>
      <paragraph num="(2)">
        <text>The payment of a fee to file an appeal.</text>
      </paragraph>
    </paragraph>
    <paragraph num="D.">
      <text>The internal appeal procedures established by the PSAO shall be provided to the Commissioner on request.</text>
    </paragraph>
  </regulation>
  <regulation prefix="Regulation" num=".05" heading="Compliant Process.">
    <paragraph num="A.">
      <text>Prior to filing a complaint with the Commissioner, a contracted pharmacy or its designee shall exhaust the internal appeal process established by the PSAO.</text>
    </paragraph>
    <paragraph num="B.">
      <text>A complaint is properly completed and may be filed if a contracted pharmacy or designee for the pharmacy:</text>
      <paragraph num="(1)">
        <text>Completes all applicable portions of the Commissioner’s complaint form; and</text>
      </paragraph>
      <paragraph num="(2)">
        <text>Provides a copy of the relevant contract or the provisions that are related to the internal dispute, including but not limited to any applicable remittance and copy of any appeal decision.</text>
      </paragraph>
    </paragraph>
    <paragraph num="C.">
      <text>Notification of the complaint to the PSAO.</text>
      <paragraph num="(1)">
        <text>Upon receipt of a completed complaint form, the Commissioner shall provide a copy to the PSAO.</text>
      </paragraph>
      <paragraph num="(2)">
        <text>Within 15 working days of receiving the Commissioner’s notice, the PSAO shall provide the Commissioner with:</text>
        <paragraph num="(a)">
          <text>A complete, unredacted copy of the applicable portion of the pharmacy services administrative contract relating to the complaint filed with the Commissioner, including any other contract applicable to the complaint; and</text>
        </paragraph>
        <paragraph num="(b)">
          <text>Any other information the Commissioner may require for the purposes of determining a PSAO’s compliance with:</text>
          <paragraph num="(i)">
            <text>The Insurance Article, Annotated Code of Maryland;</text>
          </paragraph>
          <paragraph num="(ii)">
            <text>This chapter; or</text>
          </paragraph>
          <paragraph num="(iii)">
            <text>The applicable terms of the applicable pharmacy services administrative contract, PBM contract, or applicable purchaser’s contract.</text>
          </paragraph>
        </paragraph>
      </paragraph>
    </paragraph>
  </regulation>
  <annotations>
    <annotation type="Authority">Insurance Article, §§15-2001—15-2019, Annotated Code of Maryland</annotation>
    <annotation type="History" subtype="Administrative History">Effective date:  December 26, 2022 (49:26 Md. R. 1081)</annotation>
  </annotations>
</chapter>